3-Aminopyrazole inhibitors of cyclin dependent kinases
US6610724B2 · kind B2 · utility
0Cited by
3References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2002 |
| Grant date | Aug 26, 2003 |
| Priority date | — |
| Expiry date | Aug 15, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes compounds of formula I and pharmaceutically acceptable salts thereof.The formula I compounds are protein kinase inhibitors and are useful in the treatment of proliferative diseases, for example, cancer, inflammation and arthritis. They may also be useful in the treatment of Alzheimer's disease, and cardiovascular disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.